The company MC10 Inc.www.mc10inc.com a pioneer in biometric sensor-enabled analytics located in Massachusetts is collaborating with the University of Rochester www.rochester.edu to unite MC10s technological capabilities in physiological sensing and pattern recognition algorithms with the University’s clinical expertise and knowledge of big data analytics.
MC10 is working with the university’s Goergen Institute for Data Science www.rochester.edu/data-science. The company is going to support the research efforts with their BioStamp platform containing MC 10’s biometric sensing devices, a companion software application, and an end-to-end cloud storage and computing platform.
BioStamp will be tested in a variety of clinical settings by a diverse group of Rochester researchers. This will make it possible for MC10’s collection of big data and the development of disease specific algorithms to be used in predictive health analytics.
According to Dr. Ray Dorsey, Professor of Neurology and Co-Director of the Center for Human Experimental Therapeutics, “Connected health technologies hold the potential to disrupt the way we monitor the progression of neurodegenerative disorders and the ability to assess the response to novel therapeutics. Wearable sensors can enable objective, sensitive, and frequent assessments of an individual’s condition to advance new treatments for neurological conditions.”